Conversely, as kidney function declines, retention of uraemic toxins, oxidative stress, and renin–angiotensin–aldosterone activation aggravate insulin resistance, dyslipidemia, and systemic inflammation, worsening hepatic steatosis and promoting fibrogenesis [18]. The gene discussed is REN; the disease is Hepatic steatosis.